Vertex Pharmaceuticals Incorporated announced that data on TRIKAFTA®, also known in the European Union and in the U.K. as KAFTRIO® in combination with ivacaftor, were presented at this year’s European Cystic Fibrosis Society’s 47th European Cystic Fibrosis Conference held June 5-8, 2024, in Glasgow, Scotland.
June 7, 2024
· 13 min read
